South Africa’s WTO ambassador on the logic behind a COVID-19 IP waiver

“South Africa, Mlumbi-Peter said, was fully aware that IP was not the only barrier to ramping up vaccine production. Voluntary licences, technology transfer and the sharing of clinical data as well as trade secrets could all play a part in what she called the toolkit of combating the pandemic.”

via Financial Times

How Ethiopian Airlines provided a vaccine lifeline

“So far, Ethiopian Airlines has carried more than 27m vaccines to 24 countries. It has a 54,000 sq m freezer facility in Addis Ababa for COVID-19 vaccines that can keep the temperature at -25C, and is developing a facility to make enough ice to keep vaccines ultra-cold when needed.”

via Financial Times

Indian vaccine maker extends freeze on export of COVID-19 jabs

“Strive Masiyiwa, African Union special envoy on vaccines, said on Tuesday that he was ‘beyond anger’ with the Indian manufacturer. ‘We met Serum three, four times. At the end I said: “I don’t think we should do business with these guys. They’re not reliable.” We cut off negotiations after that.'”

via Financial Times

Pandemic gives Africa a chance to free itself from aid dependency

“COVID-19 is reshaping our world in ways that require a redesign of our systems and changes in how we view our future. It is up to us as Africans to decide if we are to accept mere observer status or be a main player at the table.”

via Financial Times

Africa celebrates suspension of COVID-19 vaccine patents

“African Union officials hope that at least three countries — South Africa, Senegal and Rwanda — will develop the capacity to produce vaccines for the continent, including the mRNA-type vaccines that emerged as an innovative technology against COVID-19.”

via Financial Times

‘There are no vaccines’: COVID-19 fears rise in Africa as inoculations stall

“African health officials aim to vaccinate at least 30 percent of the 1.2 billion population by the end of the year, rising to 60 percent or higher after that. But supply constraints, logistical problems and vaccine hesitancy mean immunisation campaigns have been patchy.”

via Financial Times

South Africa health regulator recommends resuming Johnson & Johnson vaccinations

“The J&J vaccine was the only one rolled out in South Africa, until the country suspended it on Tuesday, risking further disruption to vaccinations in Africa’s most industrial economy.”

via Financial Times

Tanzania’s new president turns her back on Magufuli

“Samia Suluhu Hassan signals end to predecessor’s COVID-19 denialism and renewed focus on foreign investment”

via Financial Times

African Union halts AstraZeneca vaccine purchases oversupply concerns

“The African Union has decided to stop plans to secure Oxford/AstraZeneca coronavirus vaccines because of supply concerns from India’s Serum Institute. The Africa Centres for Disease Control and Prevention will instead focus on the single-shot vaccine from Johnson & Johnson, said John Nkengasong, the AU’s disease control unit’s director.”

via Financial Times

South African central bank bucks emerging-market trend and holds rates

“South Africa’s central bank has kept its main interest rate at a historic low of 3.5 per cent, breaking with emerging-market peers that have increased rates following this year’s surge in US Treasury yields.”

via Financial Times